Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Kulp

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Cell Reports|August 23, 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing AntibodiesLaura E McCoy, Marit J van Gils, Gabriel Ozorowski, et al.
Nature Medicine|October 21, 2025
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trialPablo Tebas, Ami Patel, Joseph T Agnes, et al.
Nature Communications|November 23, 2017
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 bindingDaniel W Kulp, Jon M Steichen, Matthias Pauthner, et al.
Science (New York, N.Y.)|March 26, 2016
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogenJoseph G Jardine, Daniel W Kulp, Colin Havenar-Daughton, et al.
Cell|September 10, 2016
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin MiceAmelia Escolano, Jon M Steichen, Pia Dosenovic, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2020
In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive ImmunityZiyang Xu, Megan C Wise, Neethu Chokkalingam, et al.
Science Translational Medicine|July 6, 2018
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogenColin Havenar-Daughton, Anita Sarkar, Daniel W Kulp, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
The Journal of Clinical Investigation|November 8, 2019
In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activityMegan C Wise, Ziyang Xu, Edgar Tello-Ruiz, et al.
Nature Medicine|May 15, 2020
Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunityTyson J Moyer, Yu Kato, Wuhbet Abraham, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Cell Reports|August 23, 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing AntibodiesLaura E McCoy, Marit J van Gils, Gabriel Ozorowski, et al.
Nature Medicine|October 21, 2025
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trialPablo Tebas, Ami Patel, Joseph T Agnes, et al.
Nature Communications|November 23, 2017
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 bindingDaniel W Kulp, Jon M Steichen, Matthias Pauthner, et al.
Science (New York, N.Y.)|March 26, 2016
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogenJoseph G Jardine, Daniel W Kulp, Colin Havenar-Daughton, et al.
Cell|September 10, 2016
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin MiceAmelia Escolano, Jon M Steichen, Pia Dosenovic, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2020
In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive ImmunityZiyang Xu, Megan C Wise, Neethu Chokkalingam, et al.
Science Translational Medicine|July 6, 2018
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogenColin Havenar-Daughton, Anita Sarkar, Daniel W Kulp, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
The Journal of Clinical Investigation|November 8, 2019
In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activityMegan C Wise, Ziyang Xu, Edgar Tello-Ruiz, et al.
Nature Medicine|May 15, 2020
Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunityTyson J Moyer, Yu Kato, Wuhbet Abraham, et al.
Pageof 8